{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-006282","form_type":"8-K","ticker":"NDRA","cik":"0001681682","company_name":"ENDRA Life Sciences Inc.","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.320567+00:00","generated_at":"2026-05-20T04:31:46.542063+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ENDRA Life Sciences receives Nasdaq delisting notice for insufficient stockholders' equity","bullets":["Stockholders' equity of $1,752,885 as of March 31, 2025, below Nasdaq's $2.5M minimum.","Nasdaq letter received May 27, 2025; company has until July 11, 2025 to submit a compliance plan.","If plan accepted, company has until November 23, 2025 to regain compliance.","Failure could lead to delisting; company intends to take measures to regain compliance, but no assurance given."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-006282","json":"https://secwatch.observer/filing/0001654954-25-006282.json","markdown":"https://secwatch.observer/filing/0001654954-25-006282.md","text":"https://secwatch.observer/filing/0001654954-25-006282.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681682/000165495425006282/0001654954-25-006282-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681682/000165495425006282/endra_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:31:46.542063+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a2b0529c5bd6aac1fe5ba8ec14f83a542e5a8968","claim":"ENDRA Life Sciences Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 27, 2025, ENDRA Life Sciences Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the Company’s stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 was $1,752,885, the Company is no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. Nasdaq’s letter has no immediate impact on the listing of the Company’s common stock, which will cont","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1681682/000165495425006282/0001654954-25-006282-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}